ALKALINE PHOSPHATASE AS A PROGNOSTIC MARKER IN CANCER BREAST PATIENTS IN A TERTIARY CARE HOSPITAL-Reference-Cited by-同舟云学术

ALKALINE PHOSPHATASE AS A PROGNOSTIC MARKER IN CANCER BREAST PATIENTS IN A TERTIARY CARE HOSPITAL

Published:2021-11-15 Issue: Volume: Page:14-16
ISSN:
Container-title:GLOBAL JOURNAL FOR RESEARCH ANALYSIS
language:en
Short-container-title:

Author:

Omega Oraon Asha Premlata¹,Rose Ekka Bela²

Affiliation:

1. MD Biochemistry, Ex-tutor, M.G. M Medical College, Jamshedpur.

2. Professor, RIMS, Ranchi.

Abstract

OBJECTIVE: To estimate the value of Alkaline Phosphatase in cancer breast patients in a tertiary care hospital. MATERIAL AND METHODS: The study was conducted to estimate the value of Serum Alkaline Phosphatase in 50 cancer breast patients and 50 normal patients of same age as a control group. RESULTS: The level of serum Alkaline Phosphatase was signicantly increased (p<0.05)in cancer patients compared to the control group. CONCLUSION: There is an increase in serum Alkaline Phosphatase in cancer patients compared to the control group and can be a prognostic markers for the progress of the disease.

Publisher

World Wide Journals

Reference12 articles.

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics.CA Cancer J Clin. 2009; 59:225-249.

2. Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thurlimann B, Senn HJ.Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer. Ann Oncol. 2009; 20:1319-1329.

3. Crivellari D, Price KN, Hagen M et al. Routine tests during follow-up of patients after primary treatment for operable breast cancer. International (Ludwig) Breast Cancer Study Group (IBCSG). Ann Oncol 1995; 6 (8): 769–776.

4. Mayne PD, Thakkar S, Rosalki SB, et al. Identification of bone and liver metastases from breast cancer by measurement of plasma alkaline phosphatase isoenzymes activity. J Clin Pathol. 1987; 40: 398 – 403.

5. Forbes, J. F. The incidence of breast cancer: the global burden, public health considerations. Semin. Oncol., 24: S120–S135, 1997.